25.01.2014 Views

Ulla Werlauff Methods to assess physical functioning - Danske ...

Ulla Werlauff Methods to assess physical functioning - Danske ...

Ulla Werlauff Methods to assess physical functioning - Danske ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PATIENTS AND METHODS<br />

Study I and II are cross-sectional studies. Study III is a retrospective study on longitudinal data.<br />

Study IV is a mixed- method study on validity of the Fatigue Severity Scale. Validity was evaluated<br />

by statistic analyses and focus group interviews.<br />

Study I describes the applicability of standard <strong>assess</strong>ment methods <strong>to</strong> characterize <strong>physical</strong> function<br />

primarily at impairment level. Study II describes the ability of clinical methods <strong>to</strong> reflect capacity<br />

and capability at impairment and activity level. Study III describes the sensitivity of clinical<br />

methods <strong>to</strong> register loss of muscle strength at impairment and activity level. Study IV evaluates the<br />

ability of a questionnaire <strong>to</strong> reflect impact of fatigue on levels of activity and participation.<br />

Criteria for inclusion in study I, II, and III were that the patients;<br />

<br />

had a genetically confirmed diagnosis of spinal muscular atrophy<br />

<br />

<br />

had a clinical diagnosis of SMA type II (study I, II and III ) and SMA III (study III) based<br />

on the established diagnostic criteria [Munsat 1997]<br />

were ≥ five years of age at time of first examination<br />

Criteria for inclusion in study IV were that patients:<br />

were diagnosed with a congenital myopathy based on muscle biopsy and/or molecular<br />

diagnosis<br />

<br />

<br />

were diagnosed with SMA II based on clinical and genetic findings<br />

were ≥ eighteen years of age<br />

Study I<br />

The <strong>to</strong>tal Danish population of 67 patients with SMA II, registered with the Danish National<br />

Rehabilitation Centre for Neuromuscular Diseases in august 2007, were invited <strong>to</strong> participate in this<br />

study. Data were obtained from 54 participants (21 females, 33 males) aged 5 – 70 years. All<br />

21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!